United Therapeutics Corp. (UTHR)
510.76
-4.70
(-0.91%)
USD |
NASDAQ |
Aug 31, 16:00
510.76
0.00 (0.00%)
After-Hours: 17:20
United Therapeutics Cash from Operations (Annual) : 1.561B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.561B |
| December 31, 2024 | 1.324B |
| December 31, 2023 | 978.00M |
| December 31, 2022 | 795.00M |
| December 31, 2021 | 598.20M |
| December 31, 2020 | 754.00M |
| December 31, 2019 | -206.60M |
| December 31, 2018 | 778.40M |
| December 31, 2017 | 474.20M |
| December 31, 2016 | 643.60M |
| December 31, 2015 | 382.76M |
| December 31, 2014 | 355.26M |
| December 31, 2013 | 425.27M |
| December 31, 2012 | 323.63M |
| Date | Value |
|---|---|
| December 31, 2011 | 250.20M |
| December 31, 2010 | 211.53M |
| December 31, 2009 | 97.62M |
| December 31, 2008 | -49.17M |
| December 31, 2007 | 49.08M |
| December 31, 2006 | 51.78M |
| December 31, 2005 | 43.70M |
| December 31, 2004 | 20.78M |
| December 31, 2003 | -8.562M |
| December 31, 2002 | -22.26M |
| December 31, 2001 | -38.90M |
| December 31, 2000 | -31.11M |
| December 31, 1999 | -23.69M |
| December 31, 1998 | -9.596M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Liquidia Corp. | -35.69M |
| MannKind Corp. | 18.26M |
| Vertex Pharmaceuticals, Inc. | 3.631B |
| Savara, Inc. | -101.04M |
| Exelixis, Inc. | 884.27M |